Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07407894 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults

Study acronym: VITAL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Feb 2026 to Feb 1, 2026v4
  2. Site contact updatedv3
  3. Secondary endpoints: 6 to 7v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
Trial Details
NCT Number NCT07407894
Lead Sponsor Synbiotic Health
Collaborators: MusB Research
Conditions
(from sponsor)		 Healthy Aging, Anti Aging
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov